The first guidelines for the screening, monitoring and treatment of interstitial lung disease (ILD) in patients with systemic autoimmune rheumatic diseases (SARDs) are now available after a major multidisciplinary effort by the ACR and the American College of Chest Physicians. These guidelines demonstrate that multidisciplinary collaborations can improve SARD-ILD management.
Luppi, F., Sebastiani, M. (2024). Guiding ILD management in systemic autoimmune rheumatic diseases. NATURE REVIEWS. RHEUMATOLOGY, 20(11), 669-670 [10.1038/s41584-024-01160-2].
Guiding ILD management in systemic autoimmune rheumatic diseases
Luppi, Fabrizio
;
2024
Abstract
The first guidelines for the screening, monitoring and treatment of interstitial lung disease (ILD) in patients with systemic autoimmune rheumatic diseases (SARDs) are now available after a major multidisciplinary effort by the ACR and the American College of Chest Physicians. These guidelines demonstrate that multidisciplinary collaborations can improve SARD-ILD management.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
